Liam Il-Young Chung

8PUBLICATIONS
47CO-AUTHORS
Tumour immunologyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 25, 2026
A phase II basket trial of DART SWOG S1609: the salivary gland tumor cohort.

|Apr 17, 2026
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: vaginal cancer sub cohort results.

|Feb 20, 2026
QVT score, a radiomic biomarker of vascular complexity, enables prognostication and monitoring of NSCLC immunotherapy.

Young K Chae, Vamsidhar Velcheti, Kai Zhang

|Apr 01, 2025
Phase II Study of Nivolumab and Ipilimumab for Treatment of Metastatic/Recurrent Adenoid Cystic Carcinoma (ACC) of all Anatomic Sites of Origin and Other Malignant Salivary Gland Tumors.

Young Kwang Chae, Richard Duan, Liam Il-Young Chung

|Nov 19, 2024
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar Cancers.

Young Kwang Chae, Lucy Corthell, Sandip Pravin Patel

|Oct 17, 2024
SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer.

Young Kwang Chae, Megan Othus, Sandip Pravin Patel

Pageof 2

Frequent Collaborators

6 joint publications

Young Kwang Chae

3 joint publications

Charles D Blanke

3 joint publications

Elad Sharon

3 joint publications

Razelle Kurzrock